However, studies also indicate that adropin-mediated immune and inflammatory regulation is involved in the pathogenesis of several metabolic and non-metabolic diseases, such as atherosclerosis (36), diabetes (58), NAFLD (59), gastric ulcers (60), and inflammatory bowel disease (18) (Table 1, Figure 3). This evidence concerns the gene ENHO and inflammatory bowel disease.